HSN Code 30021230: Antisera for Rabies

HSN Code 30021230 represents Antisera for Rabies under GST classification. This code helps businesses identify Antisera for Rabies correctly for billing, taxation, and trade. With HSN Code 30021230, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import or export of Antisera for Rabies.

Live Demo Available Today

Experience the power of Expert Accounting

Join our guided walkthrough to see how BUSY can transform your business operations.

Trusted by 6,00,000+ Users
4.6 Google Rating
+91
expand_more

* No credit card required

Description of Goods for HSN Code 30021230

HSN Code 30021230 relates to the following description.

Description of Goods

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For rabies

Chapter

30 - Pharmaceutical products

Sub Chapter

3002 - Human blood; animal blood prepared fortherapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines,toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified

CGST

6%

SGST

6%

IGST

12%

CESS

0%

What does HSN Code 30021230 not include?

Antisera for Rabies does not include products with the following descriptions.

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for diptheria

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for tetanus

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for rabies

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for snake venom

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : hemoglobin blood globulins and serum globulins

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : of human origin

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : other

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For diphtheria

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For tetanus

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For Snake venom

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : antisera: Other

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale:

Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, put up in measured doses or in forms or packings for retail sale

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for cholera and typhoid

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for hepatitis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tetanus

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for polio

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tuberculosis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for rabies

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for japanese encephalitis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for whopping cough (pertusis)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria, pertusis and tetanus (dpt)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria and tetanus (dt)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for measles, mumps and rubella (mmr)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for typhoid-paratyphoid (tab) or typhoid- paratyphoid-cholera (tabc)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for veterinary medicine

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Cholera and typhoid

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Hepatitis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tetanus

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Polio

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tuberclosis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Rabies

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Japanese encephalitis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Whopping cough (pertussis)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Other

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria, pertussis and tetanus (DPT)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria and tetanus (DT)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Measles, mumps and rubella (MMR)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid (TAB)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid-cholera (TABC)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Other

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for veterinary medicine

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Cultures of micro-organisms (excluding yeast)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Toxins

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Other

Other : Animal blood prepared for therapeutic, prophylactic or diagnostic uses

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : cultures of micro-organisms (excluding yeast)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : toxins

India’s Trade Performance — HSN Code 30021230 in FY 2024-25

TradeStat EIDB — Ministry of Commerce & Industry FY 2018-19–FY 2024-25 Values in ₹ Crore

India’s Exports

FY 2024-25

₹118 Cr

+20.84% vs FY 2023-24

0.0032% of India’s total exports

India’s Imports

FY 2024-25

₹8 Cr

−70.74% vs FY 2023-24

0.0001% of India’s total imports

Trade Balance

FY 2024-25

₹110 Cr

Trade Surplus

Surplus rank #1541 of 12657 HSN codes

% of Sub-Chapter 3002

FY 2024-25

0.78%

Share of Sub-Chapter 3002’s total exports in FY 2024-25

Import side: 0.08% of Sub-Chapter 3002’s imports

Rank Within Sub-Chapter 3002

FY 2024-25

#17 of 61

Position by export value among HSN codes in Sub-Chapter 3002

Import-side rank: #22 of 61

At a glance

11.78%

Export CAGR

FY 2018-19 → FY 2024-25 · 7 fiscal years

#2455

National Export Rank

of 12657 HSN codes by export value, FY 2024-25

+64.20%

Peak Growth Year

FY 2022-23 · strongest single-year move

0.78%

Contribution to Sub-Ch. 3002

Share of Sub-Chapter 3002 exports in FY 2024-25

India Export-Import Trade Statistics for HSN Code 30021230

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

FY 2018-19 Exp. Rank #2606

Balance

+44.93

Exports

60.56 ₹ Cr

0.0027% share

YoY

0.99% of Sub-Ch. 3002

Imports

15.63 ₹ Cr

0.0004% share

YoY

0.29% of Sub-Ch. 3002

FY 2019-20 Exp. Rank #2826

Balance

+9.28

Exports

51.84 ₹ Cr

0.0024% share

−14.40% YoY

0.70% of Sub-Ch. 3002

Imports

42.56 ₹ Cr

0.0013% share

+172.30% YoY

0.62% of Sub-Ch. 3002

FY 2020-21 Exp. Rank #3066

Balance

+35.50

Exports

46.02 ₹ Cr

0.0021% share

−11.23% YoY

0.51% of Sub-Ch. 3002

Imports

10.52 ₹ Cr

0.0004% share

−75.28% YoY

0.12% of Sub-Ch. 3002

FY 2021-22 Exp. Rank #3272

Balance

+41.61

Exports

53.61 ₹ Cr

0.0017% share

+16.49% YoY

0.49% of Sub-Ch. 3002

Imports

12.00 ₹ Cr

0.0003% share

+14.07% YoY

0.13% of Sub-Ch. 3002

FY 2022-23 Exp. Rank #2720

Balance

+66.79

Exports

88.03 ₹ Cr

0.0024% share

+64.20% YoY

0.75% of Sub-Ch. 3002

Imports

21.24 ₹ Cr

0.0004% share

+77.00% YoY

0.25% of Sub-Ch. 3002

FY 2023-24 Exp. Rank #2605

Balance

+68.92

Exports

97.76 ₹ Cr

0.0027% share

+11.05% YoY

0.70% of Sub-Ch. 3002

Imports

28.84 ₹ Cr

0.0005% share

+35.78% YoY

0.34% of Sub-Ch. 3002

FY 2024-25 Exp. Rank #2455

Balance

+109.69

Exports

118.13 ₹ Cr

0.0032% share

+20.84% YoY

0.78% of Sub-Ch. 3002

Imports

8.44 ₹ Cr

0.0001% share

−70.74% YoY

0.08% of Sub-Ch. 3002

CAGR · 7-Year

Exports

11.78% /yr

Imports

−9.76% /yr

Consistently Surplus
Sub-Chapter 3002 total

reference, FY 2024-25

Export

₹15,063.17 Cr

Import

₹11,034.41 Cr

Trade Balance

+4,028.76

Peak export growth year Latest available data Not available YoY = change vs previous FY

Key Trade Insights: HSN Code 30021230 Export-Import Analysis

Consistent Export Growth: 11.78% CAGR Over 7 Years

India's exports under HSN Code 30021230 have grown at a compound annual rate of 11.78% over 7 fiscal years, rising from ₹60.56 Crore in FY 2018-19 to ₹118.13 Crore in FY 2024-25.

HSN Code 30021230 Ranked #2455 Among All 12657 HSN codes by Export Value

In FY 2024-25, HSN Code 30021230 ranks #2455 out of 12657 HSN codes by total export value. Within Sub-Chapter 3002, it ranks #17 of 61. By trade surplus, it ranks #1541 of 12657.

FY 2022-23 Was the Strongest Growth Year for HSN Code 30021230 Exports

The strongest single-year export movement for HSN Code 30021230 was recorded in FY 2022-23, when exports surged by 64.20% over the prior year.

India Maintains a Trade Surplus of ₹109.69 Crore in HSN Code 30021230 Goods

In FY 2024-25, India's exports of ₹118.13 Cr exceeded imports of ₹8.44 Cr, resulting in a trade surplus of ₹109.69 Crore — ranking #1541 of 12657 by surplus magnitude.

Import Growth of −9.76% CAGR Signals Stable Import Dependency for Antisera for Rabies

India's imports under HSN Code 30021230 have grown at −9.76% CAGR, reaching ₹8.44 Crore in FY 2024-25.

HSN Code 30021230 Contributes 0.78% of Sub-Chapter 3002 Exports — Ranked #17

Among the 61 HSN codes under Sub-Chapter 3002, HSN Code 30021230 ranks #17 by export value — accounting for 0.78% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 0.08% share (rank #22).

Stop worrying about HSN & TAX compliance

BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.

Automatic Updates
Error-free GSTR
6,00,000+ Happy Users
+91
expand_more

* No credit card required

Frequently Asked Questions

Clear answers to common queries about HSN Code 30021230 and GST compliance.

What products are classified under HSN 30021230 ?

It includes Antisera for Rabies

How much GST applies to Antisera for Rabies?

Under HSN 30021230, Antisera for Rabies attracts Varies when sold in taxable form. Describe the exact form on the invoice.

How should mixed supplies be billed when Antisera for Rabies is sold with other items?

Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Antisera for Rabies; Nil for exempt items if applicable).

Can we claim ITC on inputs used to trade Antisera for Rabies?

If your outward supply is taxable, eligible ITC is available subject to general restrictions. For exempt/Nil supplies, reverse credit per Rule 42.

Any common misclassification issue with Antisera for Rabies?

Use the exact HSN and describe the form/grade. For multi‑line invoices, apply the rate per line to avoid wrong tax collection.

Does packaging or labelling change the GST for Antisera for Rabies?

For food/agri items, GST can be 5% when not fresh/chilled and sold as pre‑packaged & labelled; otherwise often Nil. For non‑food items, rates depend on the specific sub‑heading.

Important Disclaimer

The above does not constitute professional advice or a formal recommendation. We recommend consulting a professional tax consultant before acting on the information contained in this piece of content.